 Connection
Brian Montague to Middle Aged
This is a "connection" page, showing publications Brian Montague has written about Middle Aged.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.143 |
|
|
|
-
Nguyen JT, Rich JD, Brockmann BW, Vohr F, Spaulding A, Montague BT. A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System. J Urban Health. 2015 Aug; 92(4):635-49.
Score: 0.031
-
Ladak F, Gjelsvik A, Feller E, Rosenthal SR, Rosenthal S, Montague BT. Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007. Infection. 2012 Aug; 40(4):405-13.
Score: 0.025
-
Montague BT, Ouellette JR, Buller GK. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008 Mar; 3(2):324-30.
Score: 0.019
-
Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, Gabra N, Ramirez JA, Thai C, Chege W, Gomez Lorenzo MM, Sista N, Farrior J, Clement ME, Brown ER, Custer KL, Van Naarden J, Adams AC, Schade AE, Dabora MC, Knorr J, Price KL, Sabo J, Tuttle JL, Klekotka P, Shen L, Skovronsky DM. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. JAMA. 2021 07 06; 326(1):46-55.
Score: 0.012
-
Morrisette T, Miller MA, Montague BT, Barber GR, McQueen RB, Krsak M. On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections. J Antimicrob Chemother. 2019 08 01; 74(8):2405-2416.
Score: 0.010
-
Snyder BM, Montague BT, Anandan S, Madabhushi AG, Pragasam AK, Verghese VP, Balaji V, Sim?es EAF. Risk factors and epidemiologic predictors of blood stream infections with New Delhi Metallo-b-lactamase (NDM-1) producing Enterobacteriaceae. Epidemiol Infect. 2019 01; 147:e137.
Score: 0.010
-
Hawkins KL, Montague BT, Rowan SE, Beum R, McLees MP, Johnson S, Gardner EM. Boosted darunavir and dolutegravir dual therapy among a cohort of highly treatment-experienced individuals. Antivir Ther. 2019; 24(7):513-519.
Score: 0.010
-
Ammon B, Iroh P, Tiruneh Y, Li X, Montague BT, Rich JD, Nijhawan AE. HIV Care After Jail: Low Rates of Engagement in a Vulnerable Population. J Urban Health. 2018 08; 95(4):488-498.
Score: 0.010
-
Costa M, Montague BT, Solomon L, Sammartino C, Gutman R, Zibman C, Rosen D, Rich JD. Assessing the Effect of Recent Incarceration in Prison on HIV Care Retention and Viral Suppression in Two States. J Urban Health. 2018 08; 95(4):499-507.
Score: 0.010
-
Winston SE, Montague BT, Lopez MJ, Delong A, Lemarchand C, Bedoya A, Gillani FS, Beckwith CG. Evaluation of longitudinal clinical outcomes and adherence to care among HIV-infected refugees. J Int Assoc Provid AIDS Care. 2013 May-Jun; 12(3):202-7.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|